Quick Answer
Cell Source, Inc. reported Research And Development Expense of $1.94 million for the year ending 2022.
- Cell Source, Inc. showed an increase of +52.2% in Research And Development Expense from 2021 to 2022.
- This data is from Cell Source, Inc.'s annual report (Form 10-K), filed with the SEC on August 8, 2023.
- XBRL data for this metric is available from 2013 to 2022 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $87.4 thousand | Q3 2013: $17.2 thousand | Q1 2014: $324.4 thousand | Q2 2014: $221.0 thousand | Q3 2014: $130.0 thousand | Q1 2015: $52.7 thousand | Q2 2015: $124.5 thousand | Q3 2015: $118.6 thousand | Q1 2016: $113.4 thousand | Q2 2016: $110.2 thousand | Q3 2016: $133.9 thousand | Q1 2017: $131.7 thousand | Q2 2017: $138.6 thousand | Q3 2017: $152.7 thousand | Q1 2018: $77.6 thousand | Q2 2018: $31.9 thousand | Q3 2018: $56.5 thousand | Q1 2019: $724.7 thousand | Q2 2019: $385.8 thousand | Q3 2019: $1.16 million | Q1 2020: $257.5 thousand | Q2 2020: $159.9 thousand | Q3 2020: $257.5 thousand | Q1 2021: $235.8 thousand | Q2 2021: $355.1 thousand | Q3 2021: $446.8 thousand | Q1 2022: $464.5 thousand | Q2 2022: $555.0 thousand | Q3 2022: $468.0 thousand.
- Over the full 10 years of available data (2013 to 2022), Cell Source, Inc.'s Research And Development Expense has grown by 451.4%.
- Historical annual values: Fiscal year 2022: $1.94 million | Fiscal year 2021: $1.27 million | Fiscal year 2020: $834.9 thousand | Fiscal year 2019: $2.46 million | Fiscal year 2018: $274.9 thousand | Fiscal year 2017: $637.3 thousand | Fiscal year 2016: $554.2 thousand | Fiscal year 2015: $392.9 thousand | Fiscal year 2014: $806.2 thousand | Fiscal year 2013: $351.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: